KOL | ANDERS GLENTHØJFrom Medical Department B and Department of Pathology, Frederiksborg Central Hospital, Hillerød, Denmark |
KOL Resume for ANDERS GLENTHØJ
| Year | |
|---|---|
| 1985 | From Medical Department B and Department of Pathology, Frederiksborg Central Hospital, Hillerød, Denmark |
ANDERS GLENTHØJ: Influence Statistics
| Concept | World rank |
|---|---|
| erythema glucagonoma | #36 |
Open the FULL List in Excel | |
Prominent publications by ANDERS GLENTHØJ
A 63-year-old woman with necrolytic migratory erythema associated with a glucagonoma in the pancreas is described. The diagnosis was suggested on the basis of a characteristic lesion in skin biopsy. Infusion of somatostatin (25 micrograms/h) for 48 hours was followed by a rapid and almost complete healing of the skin eruptions. Serum glucagon was depressed during infusion. No significant changes in plasma glucose were detected. As the patient experienced a cramp-like sensation after ...
| Known for Necrolytic Migratory Erythema | Publication Adenoma | Islet Cell | Glucagonoma Humans | Pancreatic Neoplasms |
Key People For Necrolytic Migratory Erythema
ANDERS GLENTHØJ:Expert Impact
Concepts for whichANDERS GLENTHØJhas direct influence:Necrolytic migratory erythema, Migratory erythema, Necrolytic migratory, Publication adenoma, Erythema glucagonoma, Islet cell, Glucagonoma humans, Adenoma islet.
ANDERS GLENTHØJ:KOL impact
Concepts related to the work of other authors for whichfor which ANDERS GLENTHØJ has influence:Necrolytic migratory erythema, Glucagonoma syndrome, Islet cell tumors, Octreotide acetate, 21 patients, Subcutaneous injection, Nme diabetes mellitus.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |